According to Pfizer, a return to production is due to take place by the fourth quarter, and the company is "working diligently" to release products from the plant that may not have been ...
Pfizer slashed its production targets for its COVID-19 vaccine because of a lack of raw materials for its supply chain, according to press reports. The big pharma has said in recent weeks that it ...
The multinational Pfizer-BioNTech consortium has reached a deal with Brazilian laboratories Eurofarma to produce its famous COVID-19 vaccine in the South American country, it was announced Thursday.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback